Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	kinase binding	DOCK4 IL12RB2 ATN1 MAML1 NOX4 TNS2 IRS1 SRCIN1 WNK1 GAB2 PRKRA CD4 PER2 PKD1 LRP4 CEP152 ATF4	1.50e-05	969	107	17	GO:0019900
GeneOntologyMolecularFunction	protein kinase binding	DOCK4 IL12RB2 ATN1 MAML1 NOX4 TNS2 IRS1 SRCIN1 WNK1 GAB2 PRKRA CD4 PKD1 LRP4 CEP152 ATF4	1.62e-05	873	107	16	GO:0019901
GeneOntologyMolecularFunction	protein tyrosine kinase binding	DOCK4 NOX4 IRS1 GAB2 CD4 LRP4	1.52e-04	149	107	6	GO:1990782
GeneOntologyMolecularFunction	transcription coactivator binding	GATA1 PPARD SIX1 STAT6	2.01e-04	54	107	4	GO:0001223
GeneOntologyMolecularFunction	chromatin binding	GATA1 SIX1 RUVBL2 CRX TOX4 SUPT5H CHD5 SNAI2 FOXO4 ATF4 RERE TCF7L1	6.00e-04	739	107	12	GO:0003682
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	DMTF1 GATA1 SIX1 STAT6 CRX NKX2-8 KMT2D FOXO4 ATF4 ONECUT3	8.54e-04	560	107	10	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	DMTF1 GATA1 SIX1 STAT6 CRX NKX2-8 KMT2D FOXO4 ATF4 ONECUT3	9.26e-04	566	107	10	GO:0001216
GeneOntologyMolecularFunction	transcription coregulator binding	GATA1 PPARD SIX1 STAT6 PER2	9.45e-04	140	107	5	GO:0001221
GeneOntologyBiologicalProcess	cellular response to calcium ion	CPNE2 TRPM2 NCSTN WNK1 RASA4 RASA4B	6.15e-06	88	106	6	GO:0071277
Domain	-	HMG20A KMT2D TOX4 CHD5 TCF7L1	1.49e-05	55	106	5	1.10.30.10
Domain	Atrophin-like	ATN1 RERE	3.19e-05	2	106	2	IPR002951
Domain	Atrophin-1	ATN1 RERE	3.19e-05	2	106	2	PF03154
Domain	HMG_box_dom	HMG20A KMT2D TOX4 CHD5 TCF7L1	3.37e-05	65	106	5	IPR009071
Domain	C2_dom	CPNE2 TNS2 FER1L6 C2CD2L RASA4 RASA4B TNS1	4.16e-05	164	106	7	IPR000008
Domain	-	RASA4 RASA4B	9.54e-05	3	106	2	4.10.1130.10
Domain	Tensin_PTB	TNS2 TNS1	1.90e-04	4	106	2	IPR033929
Domain	REJ	PKD1L2 PKD1	1.90e-04	4	106	2	PS51111
Domain	REJ_dom	PKD1L2 PKD1	1.90e-04	4	106	2	IPR014010
Domain	HMG_box	HMG20A KMT2D TOX4 TCF7L1	2.32e-04	53	106	4	PF00505
Domain	HMG	HMG20A KMT2D TOX4 TCF7L1	2.49e-04	54	106	4	SM00398
Domain	-	GATA1 PPARD RXRG RERE	3.07e-04	57	106	4	3.30.50.10
Domain	Znf_NHR/GATA	GATA1 PPARD RXRG RERE	3.29e-04	58	106	4	IPR013088
Domain	-	TNS2 IRS1 GAB2 TBC1D4 RASA4 OSBPL7 RASA4B TNS1 SOS2	3.87e-04	391	106	9	2.30.29.30
Domain	PKD/REJ-like	PKD1L2 PKD1	4.72e-04	6	106	2	IPR002859
Domain	REJ	PKD1L2 PKD1	4.72e-04	6	106	2	PF02010
Domain	PH_dom-like	TNS2 IRS1 GAB2 TBC1D4 RASA4 OSBPL7 RASA4B TNS1 SOS2	7.17e-04	426	106	9	IPR011993
Domain	PTEN_C2	TNS2 TNS1	8.74e-04	8	106	2	PF10409
Domain	PTB	TNS2 TNS1	8.74e-04	8	106	2	IPR013625
Domain	PTEN_C2	TNS2 TNS1	8.74e-04	8	106	2	SM01326
Domain	PTB	TNS2 TNS1	8.74e-04	8	106	2	PF08416
Domain	C2_TENSIN	TNS2 TNS1	8.74e-04	8	106	2	PS51182
Domain	Tensin_lipid_phosphatase_dom	TNS2 TNS1	8.74e-04	8	106	2	IPR029023
Domain	Tensin_C2-dom	TNS2 TNS1	8.74e-04	8	106	2	IPR014020
Domain	BTK	RASA4 RASA4B	1.12e-03	9	106	2	SM00107
Domain	Znf_Btk_motif	RASA4 RASA4B	1.12e-03	9	106	2	IPR001562
Domain	PPASE_TENSIN	TNS2 TNS1	1.12e-03	9	106	2	PS51181
Domain	BTK	RASA4 RASA4B	1.12e-03	9	106	2	PF00779
Domain	ZF_BTK	RASA4 RASA4B	1.12e-03	9	106	2	PS51113
Domain	LAM_G_DOMAIN	LAMA5 CNTNAP5 CNTNAP2	1.30e-03	38	106	3	PS50025
Domain	PTB	TNS2 TBC1D4 TNS1	1.51e-03	40	106	3	SM00462
Domain	Laminin_G_2	LAMA5 CNTNAP5 CNTNAP2	1.51e-03	40	106	3	PF02210
Domain	-	CPNE2 FER1L6 C2CD2L RASA4 RASA4B	1.56e-03	148	106	5	2.60.40.150
Domain	PTB/PI_dom	TNS2 TBC1D4 TNS1	1.62e-03	41	106	3	IPR006020
Domain	PKD_channel	PKD1L2 PKD1	1.70e-03	11	106	2	PF08016
Domain	PKD1_2_channel	PKD1L2 PKD1	1.70e-03	11	106	2	IPR013122
Domain	PH	IRS1 GAB2 RASA4 OSBPL7 RASA4B SOS2	1.96e-03	229	106	6	PF00169
Domain	LamG	LAMA5 CNTNAP5 CNTNAP2	1.99e-03	44	106	3	SM00282
Domain	ZnF_GATA	GATA1 RERE	2.03e-03	12	106	2	SM00401
Domain	RasGAP	RASA4 RASA4B	2.78e-03	14	106	2	SM00323
Domain	RasGAP_CS	RASA4 RASA4B	2.78e-03	14	106	2	IPR023152
Domain	RasGAP	RASA4 RASA4B	3.19e-03	15	106	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA4 RASA4B	3.19e-03	15	106	2	PS00509
Domain	Znf_GATA	GATA1 RERE	3.19e-03	15	106	2	IPR000679
Domain	GATA	GATA1 RERE	3.19e-03	15	106	2	PF00320
Domain	RAS_GTPASE_ACTIV_2	RASA4 RASA4B	3.19e-03	15	106	2	PS50018
Domain	HMG_BOX_2	HMG20A TOX4 TCF7L1	3.57e-03	54	106	3	PS50118
Domain	GATA_ZN_FINGER_1	GATA1 RERE	3.64e-03	16	106	2	PS00344
Domain	GATA_ZN_FINGER_2	GATA1 RERE	3.64e-03	16	106	2	PS50114
Domain	-	RASA4 RASA4B	3.64e-03	16	106	2	1.10.506.10
Domain	Laminin_G	LAMA5 CNTNAP5 CNTNAP2	4.37e-03	58	106	3	IPR001791
Domain	LH2	PKD1L2 PKD1	4.60e-03	18	106	2	SM00308
Domain	RasGAP_dom	RASA4 RASA4B	4.60e-03	18	106	2	IPR001936
Domain	PH	IRS1 GAB2 RASA4 OSBPL7 RASA4B SOS2	5.08e-03	278	106	6	SM00233
Domain	DSRM	ADARB1 PRKRA	5.12e-03	19	106	2	SM00358
Domain	PH_DOMAIN	IRS1 GAB2 RASA4 OSBPL7 RASA4B SOS2	5.17e-03	279	106	6	PS50003
Domain	PH_domain	IRS1 GAB2 RASA4 OSBPL7 RASA4B SOS2	5.26e-03	280	106	6	IPR001849
Domain	dsrm	ADARB1 PRKRA	5.67e-03	20	106	2	PF00035
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPHK2 SZT2 CTC1 MAML1 LAMA5 IRS1 ATG2A EDC4 WNK1 REXO1 C2CD2L KMT2D PER2 CLCN7 ADAMTSL5 CHD5 PKD1 LRP4 DTX2	1.59e-09	1105	109	19	35748872
Pubmed	A census of human transcription factors: function, expression and evolution.	DMTF1 GATA1 PPARD SIX1 RXRG STAT6 CRX NKX2-8 KMT2D TOX4 SNAI2 FOXO4 ATF4 RERE ONECUT3 TCF7L1	2.53e-08	908	109	16	19274049
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	PPARD SIX1 RXRG HMG20A NKX2-8 TOX4 PER2 FOXO4 TCF7L1	1.56e-07	263	109	9	20932939
Pubmed	Functional proteomics mapping of a human signaling pathway.	DMTF1 LAMA5 PPARD ANKLE2 PIAS1 HMG20A SEC24D KMT2D TOX4 SUPT5H PKD1 INVS	3.64e-07	591	109	12	15231748
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	GATA1 PPARD SIX1 RXRG CRX NKX2-8 SNAI2 FOXO4 ATF4 ONECUT3 TCF7L1	1.20e-06	544	109	11	28473536
Pubmed	Comparative genome mapping in the sequence-based era: early experience with human chromosome 7.	DOCK4 RASA4 RASA4B	1.66e-06	8	109	3	10810084
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	DMTF1 GATA1 PPARD SIX1 PIAS1 RXRG TOX4 PER2 SNAI2 FOXO4 ATF4 TCF7L1	2.43e-06	709	109	12	22988430
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	GATA1 MAML1 PPARD SIX1 RUVBL2 RXRG STAT6 HMG20A PER2 SUPT5H ATF4 RERE VGLL1	3.84e-06	877	109	13	20211142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SZT2 MAML1 LAMA5 SRCIN1 NCSTN ATG2A ANKLE2 CHD5 CNTNAP2 LRP4	6.76e-06	529	109	10	14621295
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATXN2L ATN1 MAML1 SIX1 FAM222B DTX2	8.82e-06	152	109	6	38360978
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DMTF1 CRTC3 ATN1 PEX14 ATG2A WNK1 PIAS1 CHD5 SOS2	8.90e-06	430	109	9	35044719
Pubmed	Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia.	DOCK4 CNTNAP5	9.73e-06	2	109	2	20346443
Pubmed	Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.	TNS2 TNS1	9.73e-06	2	109	2	11792844
Pubmed	Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.	ATN1 RERE	9.73e-06	2	109	2	10814707
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	9.73e-06	2	109	2	11448776
Pubmed	Screening of chromosomal region 21q22.3 for mutations in genes associated with neuronal Ca2+ signalling in bipolar affective disorder.	TRPM2 ADARB1	9.73e-06	2	109	2	16733555
Pubmed	A single administration of recombinant human interleukin-12 is associated with increased expression levels of interferon-gamma and signal transducer and activator of transcription in healthy subjects.	IL12RB2 PIAS1	9.73e-06	2	109	2	15901746
Pubmed	Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.	PPARD RXRG	9.73e-06	2	109	2	21843636
Pubmed	Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease.	STAT6 PKD1	9.73e-06	2	109	2	22025716
Pubmed	Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.	GATA1 ITGA2B	9.73e-06	2	109	2	19682090
Pubmed	Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.	IRS1 PKD1	9.73e-06	2	109	2	27785750
Pubmed	Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.	PPARD ATF4	9.73e-06	2	109	2	23176727
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	9.73e-06	2	109	2	16041389
Pubmed	Mapping of transcription start sites of human retina expressed genes.	RBP3 CRX GUCY2D WDR17	1.23e-05	45	109	4	17286855
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 ATXN2L VPS72 ENTR1 MAML1 WNK1 RUVBL2 PIAS1 TBC1D4 SUPT5H	1.68e-05	588	109	10	38580884
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	DOCK4 IRS1 PTPN18 GAB2 SOS2	1.89e-05	103	109	5	21706016
Pubmed	A-to-I RNA editing enzyme ADAR2 regulates light-induced circadian phase-shift.	ADARB1 PER2	2.91e-05	3	109	2	30287844
Pubmed	AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.	TNS2 IRS1	2.91e-05	3	109	2	30419905
Pubmed	Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P).	SPHK2 ITGA2B	2.91e-05	3	109	2	23775711
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4 RASA4B	2.91e-05	3	109	2	25637021
Pubmed	C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy.	TNS2 IRS1	2.91e-05	3	109	2	23401856
Pubmed	RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets.	GATA1 STAT6	2.91e-05	3	109	2	25769044
Pubmed	WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4.	WNK1 FOXO4	2.91e-05	3	109	2	29904119
Pubmed	CD137 signaling induces macrophage M2 polarization in atherosclerosis through STAT6/PPARδ pathway.	PPARD STAT6	2.91e-05	3	109	2	32247042
Pubmed	SUMO modification regulates the transcriptional activity of MAML1.	MAML1 PIAS1	2.91e-05	3	109	2	20203086
Pubmed	Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.	ATN1 RERE	2.91e-05	3	109	2	19131340
Pubmed	The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction.	NOX4 IRS1	2.91e-05	3	109	2	14966267
Pubmed	Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo.	GATA1 ITGA2B	2.91e-05	3	109	2	12393529
Pubmed	IL-13 upregulates GPIIb expression in megakaryocytic cell lines via STAT6.	ITGA2B STAT6	2.91e-05	3	109	2	20652946
Pubmed	Retinal dystrophies with bull's-eye maculopathy along with negative ERGs.	CRX GUCY2D	2.91e-05	3	109	2	30945053
Pubmed	The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites.	STAT6 CD4	2.91e-05	3	109	2	20605978
Pubmed	Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes.	IL12RB2 TRPM2	2.91e-05	3	109	2	21709234
Pubmed	RUVBL2, a novel AS160-binding protein, regulates insulin-stimulated GLUT4 translocation.	RUVBL2 TBC1D4	2.91e-05	3	109	2	19532121
Pubmed	Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.	STAT6 PKD1	2.91e-05	3	109	2	29513071
Pubmed	Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis.	GATA1 STAT6	2.91e-05	3	109	2	24906147
Pubmed	Multiple roles of lymphatic vessels in peripheral lymph node development.	LAMA5 ITGA2B CD4	3.28e-05	20	109	3	30355615
Pubmed	Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.	IRS1 PPARD CUBN RXRG	3.64e-05	59	109	4	20855565
Pubmed	ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm.	ADARB1 PER2	5.82e-05	4	109	2	27893733
Pubmed	Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.	STAT6 CD4	5.82e-05	4	109	2	15096484
Pubmed	The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.	GATA1 STAT6	5.82e-05	4	109	2	28670633
Pubmed	Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex.	WNK1 TBC1D4	5.82e-05	4	109	2	20937822
Pubmed	Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing.	LAMA5 ITGA2B	5.82e-05	4	109	2	28618934
Pubmed	Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.	RASA4 RASA4B	5.82e-05	4	109	2	16234249
Pubmed	T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia.	STAT6 CD4	5.82e-05	4	109	2	11382732
Pubmed	Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.	TNS2 TNS1	5.82e-05	4	109	2	19194507
Pubmed	The eIF2α Kinase GCN2 Modulates Period and Rhythmicity of the Circadian Clock by Translational Control of Atf4.	PER2 ATF4	5.82e-05	4	109	2	31522764
Pubmed	Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.	RASA4 RASA4B	5.82e-05	4	109	2	21460216
Pubmed	Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system.	GATA1 STAT6	5.82e-05	4	109	2	16702603
Pubmed	Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease.	STAT6 PKD1	5.82e-05	4	109	2	25922073
Pubmed	WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.	WNK1 TBC1D4	5.82e-05	4	109	2	31816312
Pubmed	Functional architecture of atrophins.	ATN1 RERE	5.82e-05	4	109	2	17150957
Pubmed	The orphan nuclear receptor RORα and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.	GATA1 STAT6	5.82e-05	4	109	2	28783681
Pubmed	Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.	IL12RB2 PIAS1 PRKRA	8.29e-05	27	109	3	19604093
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 ATXN2L CRTC3 CCDC18 IRS1 EDC4 WNK1 GAB2 TBC1D4 FOXO4 CEP152	8.51e-05	861	109	11	36931259
Pubmed	IL-4-secreting eosinophils promote endometrial stromal cell proliferation and prevent Chlamydia-induced upper genital tract damage.	GATA1 STAT6	9.67e-05	5	109	2	28765368
Pubmed	FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting.	FOXO4 ATF4	9.67e-05	5	109	2	35061305
Pubmed	The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.	TNS2 TNS1	9.67e-05	5	109	2	17190795
Pubmed	Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease.	GATA1 STAT6	9.67e-05	5	109	2	18981084
Pubmed	Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.	GATA1 ITGA2B	9.67e-05	5	109	2	18371378
Pubmed	High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ.	NOX4 PPARD	9.67e-05	5	109	2	25722086
Pubmed	Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance.	IRS1 FOXO4	9.67e-05	5	109	2	23349480
Pubmed	Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins.	SPHK2 NOX4	9.67e-05	5	109	2	23933064
Pubmed	The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo.	GATA1 ITGA2B	9.67e-05	5	109	2	15882575
Pubmed	Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function.	THSD4 TNS1	9.67e-05	5	109	2	21965014
Pubmed	A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome.	RBP3 RXRG CRX GUCY2D	1.26e-04	81	109	4	16110338
Pubmed	The steroid receptor RNA activator protein is recruited to promoter regions and acts as a transcriptional repressor.	DMTF1 GATA1 ATF4	1.26e-04	31	109	3	20398657
Pubmed	cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene.	PER2 ATF4	1.45e-04	6	109	2	21768648
Pubmed	CRY1/2 Selectively Repress PPARδ and Limit Exercise Capacity.	PPARD PER2	1.45e-04	6	109	2	28683290
Pubmed	Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma.	PPARD RXRG	1.45e-04	6	109	2	22205725
Pubmed	Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.	IL12RB2 CD4	1.45e-04	6	109	2	22829762
Pubmed	SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.	IL12RB2 CD4	1.45e-04	6	109	2	16357940
Pubmed	Inflammatory monocytes are detrimental to the host immune response during acute infection with Cryptococcus neoformans.	GATA1 STAT6	1.45e-04	6	109	2	30897162
Pubmed	Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation.	CLCN7 PKD1	1.45e-04	6	109	2	15692563
Pubmed	HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.	CD4 ATF4	1.45e-04	6	109	2	14561767
Pubmed	Regulation of RUVBL1-RUVBL2 AAA-ATPases by the nonsense-mediated mRNA decay factor DHX34, as evidenced by Cryo-EM.	RUVBL2 SMG9	1.45e-04	6	109	2	33205750
Pubmed	IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.	IL12RB2 CD4	1.45e-04	6	109	2	22056381
Pubmed	A human MAP kinase interactome.	CRTC3 WNK1 PIAS1 GAB2 TOX4 ATF4 TNS1 SOS2	1.52e-04	486	109	8	20936779
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPM2 PKD1L2 PKD1	1.53e-04	33	109	3	19834762
Pubmed	Human transcription factor protein interaction networks.	ATN1 VPS72 ENTR1 GATA1 MAML1 MRPS16 EDC4 RUVBL2 PIAS1 HMG20A KMT2D CHD5 CEP152 RERE	1.54e-04	1429	109	14	35140242
Pubmed	Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model.	CUBN PKD1 INVS	1.98e-04	36	109	3	33737325
Pubmed	Mutations that are a common cause of Leber congenital amaurosis in northern America are rare in southern India.	CRX GUCY2D	2.02e-04	7	109	2	19753312
Pubmed	Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors.	ATN1 RERE	2.02e-04	7	109	2	16481466
Pubmed	High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.	PPARD RXRG	2.02e-04	7	109	2	17272748
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	ATN1 RERE	2.02e-04	7	109	2	22510986
Pubmed	IL-4/IL-13 signaling beyond JAK/STAT.	IRS1 STAT6	2.02e-04	7	109	2	10856136
Pubmed	'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR.	STAT6 CD4	2.02e-04	7	109	2	17873878
Pubmed	Mouse prenatal platelet-forming lineages share a core transcriptional program but divergent dependence on MPL.	GATA1 ITGA2B	2.02e-04	7	109	2	25995324
Pubmed	A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.	GATA1 STAT6	2.02e-04	7	109	2	18316626
Pubmed	Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.	GATA1 STAT6	2.02e-04	7	109	2	24906148
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	CRTC3 WDR46 NOX4 CUBN DIPK2B SUPT5H SERTAD4 FOXO4 DTX2 LRRN4 ALDH3B2 WDR17 INVS	2.09e-04	1293	109	13	15342556
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TNS2 TNS1	1.55e-04	5	72	2	902
GeneFamily	ADAMTS like	THSD4 ADAMTSL5	3.24e-04	7	72	2	947
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TNS2 TNS1	4.31e-04	8	72	2	837
GeneFamily	INO80 complex \|SRCAP complex	VPS72 RUVBL2	5.53e-04	9	72	2	1329
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	6.89e-04	10	72	2	830
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	IRS1 GAB2 OSBPL7 RASA4B SOS2	1.38e-03	206	72	5	682
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATA1 RERE	1.59e-03	15	72	2	82
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ATXN2L SPHK2 ATN1 SZT2 PPARD REXO1 KMT2D SMG9 FOXO4	1.13e-05	338	108	9	M17094
Coexpression	VEGF_A_UP.V1_UP	TNS2 ADARB1 KMT2D PER2 GUCY2D PKD1 MN1	1.67e-05	195	108	7	M2676
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	SZT2 GATA1 PIAS1 TRIL CLCN7 FAM222B TCF7L1	1.91e-05	199	108	7	M7254
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 CRTC3 SLC6A17 LAMA5 SIX1 TNS1 TCF7L1	3.58e-07	184	109	7	94748f63947db79a6b4540e3090a63689fdd9452
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 CRTC3 SLC6A17 LAMA5 SIX1 TNS1 TCF7L1	3.58e-07	184	109	7	819b277ecced7b415e363c7e7ddbc6f3b2d296de
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	BOC DOCK4 ADARB1 TRIL SNAI2 LRP4 TNS1	4.60e-07	191	109	7	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	BOC DOCK4 ADARB1 SNAI2 SERTAD4 LRP4 TNS1	4.60e-07	191	109	7	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DPP6 CUBN CSMD3 FER1L6 CNTNAP5 CNTNAP2	1.22e-06	139	109	6	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3\|E16.5-samps / Age Group, Lineage, Cell class and subclass	BOC DOCK4 RXRG TRIL SNAI2 SOS2	1.82e-06	149	109	6	651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell	Basal_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	PODNL1 SIX1 SNAI2 CNTNAP2 LRP4 VGLL1	3.41e-06	166	109	6	23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell	droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 MBOAT1 TRPM2 GATA1 ITGA2B TBC1D4	4.32e-06	173	109	6	120dd20e8a71f9169a1596b6171df7aa0b96dd15
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 GATA1 GAB2 TBC1D4 CHD5	4.32e-06	173	109	6	53e97835d7a518c278e7b90a0734eb0095d6aa33
ToppCell	droplet-Lung-LUNG-1m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 GATA1 GAB2 TBC1D4 CHD5	4.32e-06	173	109	6	889a880de5fc19d26b82cfef3067869a28ef17ca
ToppCell	droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 MBOAT1 TRPM2 GATA1 ITGA2B TBC1D4	4.32e-06	173	109	6	b2c55084ef6dac0e329c2e65c24cfe0045859c30
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTC1 CCDC18 PPARD PKD1L2 C2CD2L CHD5	4.93e-06	177	109	6	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 GATA1 LAMA5 ITGA2B GAB2 TBC1D4	5.09e-06	178	109	6	41745a589567ca5ea6d06331f4c8da03595b5f5c
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 GATA1 LAMA5 ITGA2B GAB2 TBC1D4	5.09e-06	178	109	6	eb940dd64c973f68bcaad6069d3bd56383329db5
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRTC3 SLC6A17 LAMA5 SIX1 TNS1 TCF7L1	5.78e-06	182	109	6	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	BOC ADARB1 TRIL SNAI2 LRP4 TNS1	6.96e-06	188	109	6	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	DPP6 RXRG CNTNAP5 CHD5 CNTNAP2 SERTAD4	7.40e-06	190	109	6	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK4 NOX4 ADARB1 SNAI2 LRP4 TNS1	7.62e-06	191	109	6	beb5bb42bd53bce01339da9110d374901548793c
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK4 NOX4 ADARB1 SNAI2 LRP4 TNS1	7.62e-06	191	109	6	6609d85fd2577633dcc067507304a6f9e5865ca3
ToppCell	Bronchial_Biopsy\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	THSD4 LAMA5 SIX1 PER2 SNAI2 SERTAD4	9.36e-06	198	109	6	f5b7013045b61fc56894f80092f799770dde1c8f
ToppCell	droplet-Liver-nan-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 CTC1 EDC4 ANKLE2 INVS	1.53e-05	127	109	5	39fa20a55de3af1a62ab5dfa4877879db3935ac2
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 ENTR1 TRPM2 MAML1 TBC1D4	1.91e-05	133	109	5	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 ENTR1 TRPM2 MAML1 TBC1D4	1.91e-05	133	109	5	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	THSD4 CNTNAP5 CD4 TBC1D4 OSBPL7	2.53e-05	141	109	5	c7043f3b024bb16bbc89e33075f5b6ced5cb9185
ToppCell	Adult-Immune-enucleated_erythrocyte-D175\|Adult / Lineage, Cell type, age group and donor	EDC4 FER1L6 SUPT5H CHD5 PZP	3.63e-05	152	109	5	530d5427d8617dcb223d807b73abee0ef89285f3
ToppCell	facs-Marrow-T-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 GATA1 ITGA2B TBC1D4 CHD5	4.23e-05	157	109	5	ed9c9feefc06c9536c03bedbc3397a2ee492a78e
ToppCell	facs-Marrow-T-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 GATA1 ITGA2B TBC1D4 CHD5	4.23e-05	157	109	5	fddcb24776b9f86e000208bae54541b15b2adefd
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BOC PODNL1 SNAI2 LRP4 VGLL1	4.77e-05	161	109	5	da9eecf919866a9c579d7a707a996cf335213134
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BOC PODNL1 SNAI2 LRP4 VGLL1	4.77e-05	161	109	5	d431625c32f59a6b552191f3adc5198bd16ad5cf
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CPNE2 SZT2 SRCIN1 TBC1D4 SMG9	4.91e-05	162	109	5	64353d33af0e82ebb7cf2bba74d52ca0586a58fc
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CPNE2 SZT2 SRCIN1 TBC1D4 SMG9	5.06e-05	163	109	5	9f5facfa1864eb63e2f8022ad7379d9252b7a254
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 LAMA5 ITGA2B GAB2 TBC1D4	5.52e-05	166	109	5	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 LAMA5 ITGA2B GAB2 TBC1D4	5.52e-05	166	109	5	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PODNL1 PEX14 SRCIN1 CSMD3 REXO1	5.68e-05	167	109	5	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODNL1 CCDC18 SMG9 CEP152 LRRN4	5.84e-05	168	109	5	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC PODNL1 DPP6 LAMA5 PCBP4	6.18e-05	170	109	5	7653f1205d4e62abe7e31b1d76f9bbd665e45667
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IL12RB2 CSMD3 FER1L6 CNTNAP5 CNTNAP2	6.35e-05	171	109	5	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	droplet-Lung-nan-21m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 GATA1 ITGA2B TBC1D4	6.53e-05	172	109	5	1b133be191252e7053faeacf9547730c3ae28d21
ToppCell	droplet-Lung-nan-21m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 GATA1 ITGA2B TBC1D4	6.53e-05	172	109	5	b3c53fd7e50f36de6a8585ae21d04e17932f262c
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MBOAT1 GATA1 ITGA2B PTPN18 TBC1D4	6.71e-05	173	109	5	8ca650542655c27516029e5bace97ff1b9dcc256
ToppCell	droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBOAT1 GATA1 ITGA2B GAB2 TBC1D4	6.71e-05	173	109	5	117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MBOAT1 GATA1 ITGA2B PTPN18 TBC1D4	6.71e-05	173	109	5	4282b47b33325472f52a4085986988911a372ed8
ToppCell	droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBOAT1 GATA1 ITGA2B GAB2 TBC1D4	6.71e-05	173	109	5	01df9baeedf30e3a4891738554cdd300394dbb96
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 MBOAT1 GATA1 ITGA2B TBC1D4	6.89e-05	174	109	5	009e88a6c79689a5d88b0af50aa89aa03b33f800
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 IL12RB2 ATG2A CD4 OSBPL7	6.89e-05	174	109	5	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 MBOAT1 GATA1 ITGA2B TBC1D4	6.89e-05	174	109	5	31f7127faabcb1092bb9827db625f57cf7d8240e
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBOAT1 GATA1 ITGA2B SIX1 TBC1D4	6.89e-05	174	109	5	e9e4532a474b4b0938a50ff85c9508aca53cd3ae
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 IL12RB2 ATG2A CD4 OSBPL7	6.89e-05	174	109	5	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 MBOAT1 GATA1 ITGA2B TBC1D4	6.89e-05	174	109	5	8a8e98e62c2859c004b44dbce6974c9639ebeac6
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 ITGA2B TBC1D4 NPFF	7.08e-05	175	109	5	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 ITGA2B TBC1D4 NPFF	7.08e-05	175	109	5	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MBOAT1 IRS1 CSMD3 CNTNAP5 TBC1D4	8.30e-05	181	109	5	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 ADARB1 TRIL SNAI2 TNS1	8.52e-05	182	109	5	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 NOX4 ADARB1 SNAI2 TNS1	8.52e-05	182	109	5	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 NOX4 ADARB1 SNAI2 TNS1	8.52e-05	182	109	5	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	COPD-Myeloid-Mast\|World / Disease state, Lineage and Cell class	DPP6 GATA1 PPARD LRP4 PZP	8.52e-05	182	109	5	68a1e7b804f309bfd6c23d65fad20a9a962712ae
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	BOC DOCK4 DIPK2B MN1 TCF7L1	8.75e-05	183	109	5	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOX4 PEX14 ADARB1 SAMD10 FOXO4	8.75e-05	183	109	5	dc9602bed3136db91faeffef177006246dc92743
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CTC1 TNS2 IRS1 ADAMTSL5 PKD1	8.75e-05	183	109	5	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA5 TNS2 DIPK2B RASA4 RASA4B	8.75e-05	183	109	5	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 BOC NKX2-8 ADAMTSL5 LRRN4	8.75e-05	183	109	5	ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BOC DOCK4 DIPK2B MN1 TCF7L1	8.97e-05	184	109	5	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC28A3 SEC24D SNAI2 SERTAD4 MN1	9.20e-05	185	109	5	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 MBOAT1 LAMA5 ITGA2B TBC1D4	9.20e-05	185	109	5	5527fa9d2e0b2f3607602e18ba94de4e9bbc6824
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	CPNE2 IL12RB2 MBOAT1 CD4 TBC1D4	9.20e-05	185	109	5	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SZT2 SLC6A17 CSMD3 CNTNAP2 ONECUT3	9.44e-05	186	109	5	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	Cerebellum-Neuronal\|Cerebellum / BrainAtlas - Mouse McCarroll V32	TRPM2 ADARB1 SAMD10 CHD5 CNTNAP2	9.68e-05	187	109	5	61b9d6eb131a674598aa8409d7fa909c8765442d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BOC DOCK4 SNAI2 OSBPL7 MN1	1.02e-04	189	109	5	e60a3d6aa84788c29f23439f1c747431ea581bc3
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC NOX4 TRIL LRP4 TNS1	1.02e-04	189	109	5	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RXRG CD4 CNTNAP2 SERTAD4 WDR17	1.02e-04	189	109	5	3e8e30160a8d6f531ff743cb5918c9e79481f1bd
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC NOX4 TRIL LRP4 TNS1	1.02e-04	189	109	5	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 ADARB1 TRIL SNAI2 TNS1	1.02e-04	189	109	5	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RXRG CD4 CNTNAP2 SERTAD4 WDR17	1.02e-04	189	109	5	851f8144aed5c7f80302911cd6b03f14bde7b56d
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC NOX4 TRIL LRP4 TNS1	1.02e-04	189	109	5	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOX4 ADARB1 SNAI2 LRP4 TNS1	1.04e-04	190	109	5	00fd993675faf53adf985b9316a18c8a33242029
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 ADARB1 TRIL SNAI2 TNS1	1.04e-04	190	109	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	Control-Myeloid-Transitioning_MDM\|Control / group, cell type (main and fine annotations)	DOCK4 TRPM2 PPARD GAB2 MS4A6A	1.04e-04	190	109	5	d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC NOX4 TRIL LRP4 TNS1	1.04e-04	190	109	5	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 DPP6 LRP4 RERE TCF7L1	1.04e-04	190	109	5	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA5 TNS2 DIPK2B RASA4 RASA4B	1.04e-04	190	109	5	141266bf411ea675fbf889b20c1b08673c45ff95
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOX4 ADARB1 SNAI2 LRP4 TNS1	1.04e-04	190	109	5	8cda09d761c6b504a744959d587c183f94f1beeb
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOX4 ADARB1 SNAI2 LRP4 TNS1	1.07e-04	191	109	5	80484d39f34703a33b9bac09826b7a526e883cab
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOX4 ADARB1 SNAI2 LRP4 TNS1	1.07e-04	191	109	5	5c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BOC DOCK4 DIPK2B TNS1 TCF7L1	1.07e-04	191	109	5	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DPP6 CNTNAP5 CHD5 CNTNAP2 WDR17	1.07e-04	191	109	5	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DPP6 CNTNAP5 CHD5 CNTNAP2 WDR17	1.07e-04	191	109	5	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 IRS1 ADARB1 TRIL LRP4	1.10e-04	192	109	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD4 IRS1 TRIL SNAI2 TNS1	1.12e-04	193	109	5	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THSD4 DOCK4 PPARD GAB2 RERE	1.12e-04	193	109	5	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP6 SRCIN1 CNTNAP5 CHD5 PCBP4	1.12e-04	193	109	5	a189d46c39067b717509cd144e0225cc93d7731d
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 TRIL SNAI2 LRP4 TNS1	1.15e-04	194	109	5	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TRPM2 MAML1 RASA4 OSBPL7 MS4A6A	1.15e-04	194	109	5	58046894446cb250814252a23f60fdd59c114d77
ToppCell	PND01-Mesenchymal-Mesenchymal_structural\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NOX4 ADARB1 TRIL SNAI2 TNS1	1.18e-04	195	109	5	6bb6349d6ec8da094fe1c7c590021989337aeb0b
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NOX4 ADARB1 TRIL SNAI2 TNS1	1.18e-04	195	109	5	a3b468125e48f072255cede7645f6692298ecf54
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 DOCK4 DPP6 LRP4 RERE	1.21e-04	196	109	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 TRIL SNAI2 LRP4 TNS1	1.21e-04	196	109	5	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMA5 IRS1 SIX1 SNAI2 SERTAD4	1.21e-04	196	109	5	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD4 SIX1 SNAI2 CNTNAP2 LRP4	1.21e-04	196	109	5	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NOX4 ADARB1 TRIL SNAI2 TNS1	1.24e-04	197	109	5	06a0d7062dadda656decaf77dcef9a10b5f2698d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BOC DOCK4 ADARB1 DIPK2B MN1	1.24e-04	197	109	5	cd509e49bbdbf991cc5913960ff3ef275ad40628
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	THSD4 ATN1 PPARD CUBN WNK1 CNTNAP2 CEP152 TNS1	3.69e-06	195	106	8	3991_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ATXN2L PODNL1 ATN1 TNS2 ITGA2B C2CD2L CLCN7 CNTNAP2	4.13e-06	198	106	8	5583_DN
Drug	Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A	DOCK4 SPHK2 TRPM2 SIX1 CD4 GUCY2D CNTNAP2 TNS1	4.13e-06	198	106	8	6033_UP
Drug	Day8ra	BOC NPFF	2.15e-05	2	106	2	CID000132122
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ATXN2L ITGA2B PPARD WNK1 PTPN18 CLCN7 TNS1	3.17e-05	191	106	7	3815_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ATXN2L SPHK2 ATN1 SZT2 CLCN7 RERE SOS2	3.39e-05	193	106	7	3250_UP
Drug	rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A	GATA1 SIX1 HMG20A MINDY3 CD4 ALDH3B2 SOS2	3.50e-05	194	106	7	430_DN
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	ATXN2L ITGA2B STAT6 C2CD2L CD4 CLCN7 SOS2	3.50e-05	194	106	7	4552_UP
Drug	phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA	DMTF1 LAMA5 EDC4 PTPN18 GAB2 SEC24D TBC1D4	3.62e-05	195	106	7	1138_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	ATN1 TNS2 SIX1 WNK1 ADARB1 PCBP4 SOS2	3.62e-05	195	106	7	3909_DN
Drug	Tolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A	PPARD WNK1 ADARB1 PER2 CNTNAP2 TNS1 SOS2	3.62e-05	195	106	7	4003_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	TNS2 SIX1 PTPN18 ADARB1 MINDY3 SNAI2 CEP152	3.74e-05	196	106	7	3255_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SPHK2 SEC24D FAM222B SMG9 RERE PCBP4 SOS2	3.74e-05	196	106	7	7353_DN
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	TRPM2 PPARD ADARB1 CLCN7 CNTNAP2 LRP4 MN1	3.74e-05	196	106	7	5606_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	SPHK2 PEX14 EDC4 SIX1 WNK1 PTPN18 PCBP4	3.74e-05	196	106	7	7314_DN
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; HL60; HT_HG-U133A	DOCK4 TRPM2 PPARD STAT6 C2CD2L TNS1 SOS2	3.74e-05	196	106	7	2516_DN
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; HL60; HT_HG-U133A	SPHK2 CTC1 TNS2 IRS1 ADARB1 TBC1D4 PER2	3.86e-05	197	106	7	2452_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	ATXN2L ATN1 PPARD PER2 CNTNAP2 RERE TNS1	3.86e-05	197	106	7	3801_DN
Drug	Fosfosal [6064-83-1]; Up 200; 18.4uM; PC3; HT_HG-U133A	IL12RB2 ATN1 MAML1 ITGA2B CHD5 CNTNAP2 TNS1	3.86e-05	197	106	7	4239_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	SPHK2 ITGA2B ADARB1 CD4 CLCN7 FOXO4 MN1	3.86e-05	197	106	7	3786_DN
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	PODNL1 EDC4 ADARB1 FAM222B CNTNAP2 PCBP4 VGLL1	3.86e-05	197	106	7	6428_DN
Drug	rotenone; Down 200; 1uM; PC3; HT_HG-U133A	ATN1 PPARD CNTNAP2 RERE TNS1 VGLL1 SOS2	3.86e-05	197	106	7	5948_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A	MAML1 PEX14 NCSTN ADARB1 MINDY3 TOX4 CLCN7	3.86e-05	197	106	7	2768_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A	DPP6 SPHK2 SZT2 CD4 RERE MS4A6A TCF7L1	3.99e-05	198	106	7	3624_UP
Drug	Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	ATXN2L ITGA2B ATG2A ADARB1 STAT6 RERE SOS2	3.99e-05	198	106	7	4529_UP
Drug	NS-398; Up 200; 10uM; PC3; HT_HG-U133A	PPARD PTPN18 ADARB1 TOX4 CD4 CLCN7 MN1	3.99e-05	198	106	7	6892_UP
Drug	Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; PC3; HT_HG-U133A	PPARD STAT6 C2CD2L CHD5 CNTNAP2 ALDH3B2 SOS2	3.99e-05	198	106	7	4062_UP
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	ATN1 WNK1 CD4 PER2 SUPT5H CNTNAP2 TNS1	3.99e-05	198	106	7	4669_DN
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	PODNL1 SPHK2 CTC1 WNK1 CLCN7 CNTNAP2 SOS2	3.99e-05	198	106	7	5445_DN
Drug	Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A	SEC24D TOX4 TBC1D4 FAM222B SNAI2 RERE ALDH3B2	3.99e-05	198	106	7	6264_DN
Drug	Sulfabenzamide [127-71-9]; Up 200; 14.4uM; PC3; HT_HG-U133A	ATXN2L PODNL1 ATN1 C2CD2L CNTNAP2 RERE SOS2	4.12e-05	199	106	7	6634_UP
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; PC3; HT_HG-U133A	ATXN2L PPARD WNK1 ADARB1 CNTNAP2 RERE SOS2	4.12e-05	199	106	7	3987_UP
Drug	leukotoxin B (12,13-EODE); Down 200; 0.2uM; MCF7; HT_HG-U133A_EA	DMTF1 LAMA5 GAB2 C2CD2L SMG9 RERE ALDH3B2	4.12e-05	199	106	7	1108_DN
Drug	DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A	ATN1 TNS2 PTPN18 CNTNAP2 OSBPL7 TNS1 TCF7L1	4.12e-05	199	106	7	7518_DN
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; PC3; HT_HG-U133A	CTC1 PPARD CLCN7 CNTNAP2 LRP4 VGLL1 SOS2	4.12e-05	199	106	7	4206_UP
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A	PODNL1 ATN1 GUCY2D CNTNAP2 LRP4 CEP152 SOS2	4.12e-05	199	106	7	4330_UP
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; HL60; HT_HG-U133A	TRPM2 MAML1 WNK1 STAT6 MINDY3 SEC24D FOXO4	4.25e-05	200	106	7	2939_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A	DOCK4 WNK1 MINDY3 CNTNAP2 LRP4 CEP152 TNS1	4.25e-05	200	106	7	1524_UP
Drug	MePEG aldehyde	BOC CD4	6.42e-05	3	106	2	CID003081726
Drug	phorbol 12-myristate	DMTF1 SPHK2 GATA1 IRS1 ITGA2B CD4 PKD1	2.23e-04	261	106	7	CID000107854
Drug	mono-(2-ethylhexyl)phthalate	DPP6 IRS1 PPARD CUBN PTPN18 RXRG CNTNAP5 TBC1D4 PER2 CHD5 WDR17	2.50e-04	658	106	11	ctd:C016599
Drug	2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A	SZT2 ITGA2B CLCN7 FOXO4 TNS1 TCF7L1	2.59e-04	189	106	6	4464_UP
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	PODNL1 SZT2 CLCN7 GUCY2D FOXO4 SOS2	2.90e-04	193	106	6	4431_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A	THSD4 SPHK2 CLCN7 CNTNAP2 FOXO4 TNS1	2.90e-04	193	106	6	4503_UP
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A	ATN1 TRPM2 PTPN18 C2CD2L RERE SOS2	2.90e-04	193	106	6	4202_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	THSD4 PODNL1 SZT2 CNTNAP2 TNS1 TCF7L1	2.98e-04	194	106	6	4182_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ITGA2B NKX2-8 CD4 CLCN7 RERE TNS1	2.98e-04	194	106	6	2258_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	ATXN2L ITGA2B WNK1 PTPN18 PCBP4 SOS2	2.98e-04	194	106	6	3674_DN
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A	TNS2 MINDY3 SEC24D CLCN7 ALDH3B2 SOS2	3.06e-04	195	106	6	2875_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ATXN2L SLC28A3 ADARB1 CD4 CHD5 INVS	3.06e-04	195	106	6	6039_UP
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	TRPM2 ADARB1 SEC24D PER2 RERE TNS1	3.06e-04	195	106	6	2290_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	ATXN2L ATN1 WNK1 ADARB1 FAM222B SOS2	3.06e-04	195	106	6	4235_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	PPARD ADARB1 SEC24D PCBP4 MN1 SOS2	3.06e-04	195	106	6	4597_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A	PPARD MINDY3 CLCN7 ALDH3B2 MS4A6A SOS2	3.06e-04	195	106	6	6235_UP
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	ATXN2L CTC1 ITGA2B PPARD ADARB1 PER2	3.06e-04	195	106	6	3806_DN
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A	SPHK2 CTC1 TNS2 STAT6 HMG20A SOS2	3.06e-04	195	106	6	6245_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	SPHK2 ATN1 ITGA2B ADARB1 OSBPL7 RERE	3.06e-04	195	106	6	6691_UP
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	ATN1 PPARD CD4 PER2 CNTNAP2 FOXO4	3.06e-04	195	106	6	3669_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	SZT2 ITGA2B PPARD CLCN7 RERE SOS2	3.06e-04	195	106	6	3732_DN
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ATN1 CHD5 CNTNAP2 RERE TNS1 SOS2	3.06e-04	195	106	6	2260_UP
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A	ATXN2L ITGA2B CUBN CD4 CLCN7 SNAI2	3.15e-04	196	106	6	5771_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A	PODNL1 SZT2 CTC1 PPARD WNK1 TNS1	3.15e-04	196	106	6	2951_UP
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; MCF7; HT_HG-U133A	ATXN2L ATN1 SIX1 CLCN7 ALDH3B2 SOS2	3.15e-04	196	106	6	7055_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	TNS2 PTPN18 GAB2 C2CD2L CLCN7 SMG9	3.15e-04	196	106	6	2090_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; HL60; HT_HG-U133A	PTPN18 GAB2 TOX4 CD4 CLCN7 CEP152	3.15e-04	196	106	6	2339_DN
Drug	Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ATXN2L PODNL1 SPHK2 SZT2 FOXO4 SOS2	3.15e-04	196	106	6	3305_UP
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A	THSD4 ATXN2L ITGA2B C2CD2L CNTNAP2 OSBPL7	3.15e-04	196	106	6	4596_UP
Drug	Aztreonam [78110-38-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PODNL1 PER2 CLCN7 OSBPL7 TNS1 SOS2	3.15e-04	196	106	6	2282_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A	ATXN2L SEC24D NKX2-8 KMT2D MS4A6A TCF7L1	3.15e-04	196	106	6	5989_UP
Drug	Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A	IL12RB2 ATN1 TNS2 PPARD MINDY3 PER2	3.15e-04	196	106	6	3849_UP
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; HL60; HT_HG-U133A	ATXN2L SPHK2 WNK1 MINDY3 TNS1 SOS2	3.15e-04	196	106	6	2925_DN
Drug	ATN-2	ATN1 RERE	3.18e-04	6	106	2	CID003081684
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A	SZT2 CTC1 SEC24D TBC1D4 FAM222B TNS1	3.24e-04	197	106	6	5785_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SPHK2 ATG2A ADARB1 PER2 CLCN7 SOS2	3.24e-04	197	106	6	3886_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A	ATXN2L MAML1 ITGA2B PPARD C2CD2L PCBP4	3.24e-04	197	106	6	7520_UP
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	ITGA2B PPARD SEC24D RERE TNS1 SOS2	3.24e-04	197	106	6	3800_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATXN2L SPHK2 SZT2 CNTNAP2 TNS1 SOS2	3.24e-04	197	106	6	4764_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HT_HG-U133A	PODNL1 SPHK2 ATN1 WNK1 LRP4 INVS	3.24e-04	197	106	6	6683_UP
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	ATXN2L TNS2 KMT2D CNTNAP2 TNS1 MN1	3.24e-04	197	106	6	6091_UP
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A	THSD4 DOCK4 IL12RB2 ITGA2B TBC1D4 CHD5	3.24e-04	197	106	6	2241_UP
Drug	Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A	ATN1 ITGA2B CD4 FOXO4 RERE MS4A6A	3.24e-04	197	106	6	4475_UP
Drug	PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A	THSD4 ATN1 C2CD2L CD4 CLCN7 CNTNAP2	3.24e-04	197	106	6	4559_UP
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A	IL12RB2 SPHK2 PPARD CLCN7 ALDH3B2 SOS2	3.24e-04	197	106	6	4078_UP
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A	DOCK4 ATXN2L PODNL1 ATN1 IRS1 PCBP4	3.24e-04	197	106	6	2401_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A	CTC1 PPARD PIAS1 C2CD2L CD4 TCF7L1	3.24e-04	197	106	6	203_UP
Drug	SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A	ATG2A EDC4 WNK1 PTPN18 SMG9 CEP152	3.24e-04	197	106	6	6909_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	ATXN2L ATN1 SEC24D CD4 CLCN7 FOXO4	3.24e-04	197	106	6	4507_UP
Drug	Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A	PODNL1 IL12RB2 TNS2 KMT2D CNTNAP2 LRP4	3.24e-04	197	106	6	4160_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	SPHK2 ATN1 PTPN18 STAT6 CLCN7 VGLL1	3.24e-04	197	106	6	4336_DN
Drug	Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A	CD4 LRP4 FOXO4 MS4A6A MN1 TCF7L1	3.24e-04	197	106	6	2274_UP
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A	IL12RB2 PTPN18 C2CD2L SEC24D LRP4 ALDH3B2	3.24e-04	197	106	6	5462_UP
Drug	Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	WNK1 PER2 CNTNAP2 LRP4 MS4A6A SOS2	3.24e-04	197	106	6	4014_UP
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	ATXN2L PPARD ADARB1 C2CD2L CD4 SOS2	3.24e-04	197	106	6	4545_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A	SPHK2 ITGA2B CLCN7 TNS1 TCF7L1 SOS2	3.24e-04	197	106	6	3632_UP
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MAML1 PEX14 TNS2 CD4 TBC1D4 CLCN7	3.24e-04	197	106	6	3309_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	SPHK2 ATN1 SZT2 TNS2 PPARD LRP4	3.33e-04	198	106	6	3842_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; PC3; HT_HG-U133A	PPARD C2CD2L CNTNAP2 CEP152 RERE TNS1	3.33e-04	198	106	6	4074_UP
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; PC3; HT_HG-U133A	ATXN2L CTC1 PPARD ADARB1 FAM222B VGLL1	3.33e-04	198	106	6	4595_DN
Drug	Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ATXN2L PODNL1 MAML1 ADARB1 STAT6 TNS1	3.33e-04	198	106	6	3286_UP
Drug	Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HG-U133A	PODNL1 ATN1 PEX14 ITGA2B PPARD MINDY3	3.33e-04	198	106	6	1921_UP
Disease	dentatorubral-pallidoluysian atrophy (implicated_via_orthology)	ATN1 RERE	1.21e-05	2	103	2	DOID:0060162 (implicated_via_orthology)
Disease	urate measurement, bone density	THSD4 MBOAT1 LAMA5 PEX14 COL6A5 HMG20A CNTNAP5 TOX4 TCF7L1	3.24e-04	619	103	9	EFO_0003923, EFO_0004531
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP5 CNTNAP2	3.33e-04	8	103	2	DOID:0060308 (implicated_via_orthology)
Disease	RETINITIS PIGMENTOSA	RBP3 CRX	5.33e-04	10	103	2	268000
Disease	intracranial aneurysm (is_implicated_in)	KMT2D PKD1	7.78e-04	12	103	2	DOID:10941 (is_implicated_in)
Disease	prostate carcinoma (is_implicated_in)	STAT6 ATF4	9.18e-04	13	103	2	DOID:10286 (is_implicated_in)
Disease	Malignant neoplasm of breast	BOC VPS72 CUBN WNK1 CRX KMT2D PER2 CHD5 SNAI2 TNS1 TCF7L1	1.33e-03	1074	103	11	C0006142
Disease	essential tremor	CPNE2 DPP6 CNTNAP5 FAM222B	1.34e-03	136	103	4	EFO_0003108
Disease	HETE measurement	DPP6 FER1L6 CNTNAP2	1.35e-03	62	103	3	EFO_0801166
Disease	Leber congenital amaurosis	CRX GUCY2D	1.40e-03	16	103	2	cv:C0339527
Disease	venous thromboembolism, fibrinogen measurement	ATXN2L LRP4 MS4A6A	1.68e-03	67	103	3	EFO_0004286, EFO_0004623
Disease	respiratory system disease	PEX14 STAT6 OSBPL7 RERE	1.70e-03	145	103	4	EFO_0000684
Disease	Feeding difficulties	ATN1 MN1	1.78e-03	18	103	2	C0232466
Disease	breast size	DOCK4 PEX14 PZP	1.83e-03	69	103	3	EFO_0004884
Disease	nasopharyngeal neoplasm	DPP6 SLC28A3 IRS1 CNTNAP2	1.97e-03	151	103	4	EFO_0004252
Disease	urinary microalbumin measurement	CUBN CNTNAP2	2.20e-03	20	103	2	EFO_0010967
Disease	schizophrenia (is_implicated_in)	ATN1 NCSTN CNTNAP2	2.60e-03	78	103	3	DOID:5419 (is_implicated_in)
Disease	Autosomal Recessive Primary Microcephaly	ANKLE2 CEP152	2.66e-03	22	103	2	C3711387
Disease	Primary microcephaly	DPP6 CEP152	2.66e-03	22	103	2	C0431350
Disease	Leber Congenital Amaurosis	CRX GUCY2D	2.66e-03	22	103	2	C0339527
Disease	longitudinal BMI measurement	DOCK4 SLC28A3 CNTNAP2	3.00e-03	82	103	3	EFO_0005937
Disease	Autism Spectrum Disorders	DPP6 DIPK2B CNTNAP2	3.32e-03	85	103	3	C1510586

Protein segments in the cluster

Peptide	Gene	Start	Entry
DGSLAYIATQGPLPH	PTPN18	96	Q99952
FYPNPLASSLGHLPS	ERFL	251	A0A1W2PQ73
LPDLSGPHSYSPGRN	ANKLE2	886	Q86XL3
GSESLPHSAAYPFLG	CEP152	1486	O94986
ASNGNPLDPSSLHYI	CPNE2	316	Q96FN4
VHDGPNLLSPLLGSY	CSMD3	951	Q7Z407
FLQHSSPGSPSLGLQ	CTC1	491	Q2NKJ3
GHSKGPYLVSAPLST	CHD5	746	Q8TDI0
ESYLGSPQHSPSTRG	ATF4	226	P18848
DSSSGLSQGPARPYH	ATN1	146	P54259
YADGLHPTGNITGLP	C19orf18	26	Q8NEA5
YGDDPQSSPNLGHII	ALDH3B2	191	P48448
HLGLPPDSLLSYPAN	DIPK2B	86	Q9H7Y0
HLQPTGTPGTYLLQT	DMTF1	501	Q9Y222
SGGHLPQASPISVYL	ATG2A	1301	Q2TAZ0
QNLYHPGALTGTPPS	ATXN2L	911	Q8WWM7
VSINNTGLLGSYHPG	RASA4	671	O43374
SGSYIHLEPVAGTLP	PZP	451	P20742
VSINNTGLLGSYHPG	RASA4B	671	C9J798
PSSAYNGDLNGLLVP	EDC4	36	Q6P2E9
LGDGPLQHYIAVSSP	NCSTN	546	Q92542
LHLNGGSNPSESFPL	MAML1	196	Q92585
KGATIPYHPSLSLGT	PCBP4	176	P57723
EPLIDPVYGHGSQSL	MINDY3	206	Q9H8M7
LADSSNTSPGLYPHL	MAGEB6	376	Q8N7X4
SGPSQHLDSPNIGVY	GUCY2D	541	Q02846
HSIPLGQADPSLAPY	DTX2	61	Q86UW9
LATTGLNHPEVPYSS	HMG20A	26	Q9NP66
AGDLPTHDGYLPSNI	IL12RB2	791	Q99665
SLFHDPPGSYNPLTL	CLCN7	476	P51798
LQPVPHSGSSGYGSL	PER2	471	O15055
HPGVTGPLHTYSSSL	FOXO4	331	P98177
LHSRQPGSASALGYP	FAM205A	1301	Q6ZU69
PGPGDLSFQLLSHTQ	FAM222B	6	Q8WU58
LYTHLPLDGFPSAAG	LAMA5	1046	O15230
PGSALGLFPAYQHLA	NKX2-8	216	O15522
KGPSTLTAPNGHYIL	IRS1	471	P35568
PGLQYTLLSQTGPVH	ADARB1	91	P78563
PDGTQDQLLLPHAGY	ADAMTSL5	446	Q6ZMM2
GLLKYQTNLDTHPPG	NOX4	211	Q9NPH5
ANTTLVSNLYGHPPG	PKD1L2	2001	Q7Z442
TLHLYGNGLDRVPPA	PODNL1	341	Q6PEZ8
PTLLYEHPETSGLGL	FBXO43	101	Q4G163
GIFYGSNLPPTIISH	CUBN	1121	O60494
SGLTLGPPGTAHLYQ	GATA1	351	P15976
LPGHQASGQPYLSGI	BOC	911	Q9BWV1
YHSPGLISNSPVLSG	DOCK4	1831	Q8N1I0
HYEEGSPRNLGTPTS	C2CD2L	406	O14523
LDVQPSHPGLLNYSP	CCDC18	66	Q5T9S5
LGLDHNSPPSQTGGY	ENTR1	141	Q96C92
GGSLPDLTNLHYSTP	CRTC3	271	Q6UUV7
FQGHPQLESYLPGIL	COL6A5	1211	A8TX70
HLTLPQALPQYAGSG	CD4	281	P01730
PGSVLFLPHSYIGNS	MS4A6A	216	Q9H2W1
GSTYLHPLSELLGIP	MBOAT1	16	Q6ZNC8
YLAGLTGHVSSPPVN	GPR156	241	Q8NFN8
LGSNQLGPIYGHTSV	CNTNAP2	251	Q9UHC6
PLAGNYSHPGASVDL	MT-CO1	131	P00395
HYPLLLVVDGTPGSQ	DPP6	621	P42658
NPGPHYSVNALALSG	CRX	6	O43186
VNSSGSYLLLPGTPQ	CNTNAP5	371	Q8WYK1
ATARQHPLYGLSPGT	LRRN4	631	Q8WUT4
SPGSRDPAGSYHLNL	PKD1	2981	P98161
LLPYVHGNQSSPELG	PKD1	3731	P98161
SGTRGLPPTDYAHLQ	OSBPL7	286	Q9BZF2
GTIPSDSQGATPLHY	INVS	281	Q9Y283
LGGTYTTLTPLQHLP	ONECUT3	101	O60422
ALDNHLSPSAYPGLP	MN1	481	Q10571
ISGQVHGFYSLPKPS	GAB2	241	Q9UQC2
SKGAGTNHPPSNLLY	FER1L6	806	Q2WGJ9
LGSYDPLPNSHGEKL	MRPS16	51	Q9Y3D3
RGTSYQSPHGIPIDL	RUVBL2	336	Q9Y230
SPVTTYHLQRALPGG	SZT2	2976	Q5T011
PLAFDYSPGSHGLLS	REXO1	146	Q8N1G1
PNHGQTRLPGYSSAE	SOS2	471	Q07890
GGPQHALPSSSYTDL	PPARD	31	Q03181
HAQLPNGLSPLSGYS	SNAI2	66	O43623
LLPGYRGHPSFQSLV	SMG9	456	Q9H0W8
YSLPGLTASQPSHGL	SIX1	246	Q15475
LYHTSPSLGGLTRPV	SAMD10	101	Q9BYL1
IGPDYVTGSNLPSHS	WDR17	1256	Q8IZU2
TPLQDGSRTPHYGSQ	SUPT5H	791	O00267
GTSPAAAYPHTSLQL	RERE	886	Q9P2R6
PGEVIPGGNHSLYSL	SLC28A3	656	Q9HAS3
SIHLPGQSQPSDLLY	ITGA2B	831	P08514
QLTYDGHPASSPLLP	PIAS1	96	O75925
PLAGSHYRGISNPIT	SERTAD4	56	Q9NUC0
LPPQDAQTSGSLLHY	NPFF	41	O15130
HSPEGSTVTYHLLGP	PEX14	281	O75381
NESPLYLVNHGESGP	SEC24D	346	O94855
LLLSYFQGPEAGPVH	RBP3	491	P10745
ASTPLLHGEFGSYPA	SPHK2	46	Q9NRA0
EPLYAAFPGSHLTNG	SRCIN1	261	Q9C0H9
LTPLITYSNDHFSPG	TCF7L1	191	Q9HCS4
GSLGAQPLLQPSHYG	STAT6	816	P42226
QPLLQPSHYGQSGIS	STAT6	821	P42226
RSFHGPYTVQAGLPL	TRPM2	1311	O94759
PSPHDVLTYSLGGNF	TRIL	56	Q7L0X0
SHPLTQSRSGYIPSG	TNS1	756	Q9HBL0
LSAVGTPLNALGSPY	RXRG	56	P48443
LPSQGPEYVIHGLTS	TRAV26-2	56	A0A0B4J265
TYQPLSTRTLPHGAG	WDR46	391	O15213
THPYFSVQLGPGQLS	TBC1D4	976	O60343
RLPEYTLSQEGGPAH	PRKRA	141	O75569
HRSYLGPGSTSPLET	SLC6A17	691	Q9H1V8
YITAHGLPPTASALG	VPS72	326	Q15906
GVSSYISQPGGLHPL	WNK1	1556	Q9H4A3
HGPLYQSDSGPRSGL	THSD4	221	Q6ZMP0
LAGTSSLEPGYSHPF	VGLL1	136	Q99990
LTHTRGPLDGSPYAQ	TNS2	471	Q63HR2
GNDNYLTITGPSHPF	TOX4	6	O94842
PDGSLPYLSHGASQR	KMT2D	2621	O14686
IGSQLPHPFGLTLYG	LRP4	941	O75096